After successfully completing initial projects throughout 2011, bcg2 has been awarded the Canon New Zealand Consumer business, which includes a wide range of products including cameras, lenses, printers and printing consumables.
After a competitive pitch, bcg2 Health is working with Fisher and Paykel Healthcare to launch an innovative digital consumer and trade campaign for the US market. The US is a key export market for F&P Healthcare’s range of sleep apnoea medical devices.
bcg2 has won the Tongan tourism account after a rigourous three month international pitch that saw the final two agencies present in Nuku’alofa to over 20 industry representatives. The win involves completely re-branding Tonga as a tourism destination, advertising, PR, joint ventures with travel industry and airline partners and raising Tonga’s profile in the digital space to reach potential visitors in key international markets.
‘We’re on a roll right now’ says Michael Jarvis bcg2 Managing Director, ‘a win like this matters because it shows how a local indie with access into a global network can deliver great ideas for a client who wants world class thinking. As our fifth new business win since November, four of them in pitches, we’re very pleased with how this year is tracking.’
‘Our edge was in a compelling idea that brings Tonga into focus in a simple and compelling way’ says James Blackwood bcg2 CEO and ECD. ‘I can see myself spending a lot more time doing the things I love in Tonga. It offers some of the best diving and surfing in the South Pacific plus an authentic experience that many other destinations have simply lost touch with. After the win we were honoured to present to the members of Tonga’s greater tourism industry and it was humbling to sense their enthusiasm.’
bcg2 Healthcare has picked up the launch of Avigra, from Viagra account incumbents M&C Saatchi. Avigra is the new brand for Pfizer’s “little blue pill”, to compete against a raft of expected generic brand competitors. ‘The business was awarded without a pitch’, says bcg2 Healthcare General Manager Stuart Ogden. “It’s quite an honour to be awarded the account for arguably, the world’s most recognisable pharmaceutical pill. We’re looking forward to taking the new brand in a different direction.”
